| 臺大學術典藏 |
2022-06-27T07:00:09Z |
Gefitinib or erlotinib in previously treated non–small-cell lung cancer patients: a cohort study in Taiwan
|
Chang C.-H.; Lee C.-H.; Ko J.-C.; Chang L.-Y.; Lee M.-C.; Wang J.-Y.; CHONG-JEN YU |
| 臺大學術典藏 |
2022-06-27T07:00:03Z |
Psychological distress and coping strategies among women with incurable lung cancer: a qualitative study
|
Liao Y.-C.; Liao W.-Y.; Sun J.-L.; Ko J.-C.; CHONG-JEN YU |
| 臺大學術典藏 |
2022-06-27T06:59:40Z |
Effect of β-Blocker in Treatment-Na?ve Patients With Advanced Lung Adenocarcinoma Receiving First-Generation EGFR-TKIs
|
Chang C.-H.; Lee C.-H.; Ko J.-C.; Chang L.-Y.; Lee M.-C.; Zhang J.-F.; Wang J.-Y.; Shih J.-Y.; CHONG-JEN YU |
| 臺大學術典藏 |
2022-06-27T06:59:38Z |
Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort
|
Liang S.-K.; Keng L.-T.; Chang C.-H.; Wen Y.-F.; Lee M.-R.; Yang C.-Y.; Wang J.-Y.; Ko J.-C.; Shih J.-Y.; CHONG-JEN YU |
| 臺大學術典藏 |
2022-05-13T08:04:30Z |
Tuberculosis contact investigation in an intermediate burden setting: Implications from a large tuberculosis contact cohort in Taiwan
|
Lee M.-R.; Ho C.-M.; Lee C.-H.; Lee M.-C.; Chang L.-Y.; Yu K.-L.; Ko J.-C.; Wang J.-Y.; JANN-TAY WANG; Lee L.-N. |
| 臺大學術典藏 |
2022-04-20T08:55:23Z |
Diabetes Mellitus and Latent Tuberculosis Infection: A Systemic Review and Metaanalysis
|
Lee M.-R.; Huang Y.-P.; Kuo Y.-T.; Luo C.-H.; Shih Y.-J.; Shu C.-C.; Wang J.-Y.; Ko J.-C.; Yu C.-J.; HSIEN-HO LIN |
| 臺大學術典藏 |
2022-04-19T08:09:42Z |
Playful bottle: A mobile social persuasion system to motivate healthy water intake
|
Chiu M.-C.; Chang S.-P.; Chang Y.-C.; Chu H.-H.; Chen C.C.-H.; FEI-HSIU HSIAO; Ko J.-C. |
| 臺大學術典藏 |
2022-04-15T06:39:34Z |
Playful bottle: A mobile social persuasion system to motivate healthy water intake
|
Chiu M.-C.; Chang S.-P.; Chang Y.-C.; Chu H.-H.; CHERYL CHIA-HUI CHEN; Hsiao F.-H.; Ko J.-C. |
| 臺大學術典藏 |
2021-11-24T05:47:40Z |
Seroprevalence of Aspergillus IgG and disease prevalence of chronic pulmonary aspergillosis in a country with intermediate burden of tuberculosis: a prospective observational study
|
Lee, M-R; Huang, H-L; Chen, L-C; Yang, H-C; Ko, J-C; Cheng, M-H; Chong, I-W; LI-NA LEE; Wang, J-Y; Dimopoulos, G |
| 臺大學術典藏 |
2021-11-03T02:33:01Z |
Efficacy and safety of cone-beam computed tomography-derived augmented fluoroscopy combined with endobronchial ultrasound in peripheral pulmonary lesions
|
Yu K.-L.; Yang S.-M.; Ko H.-J.; Tsai H.-Y.; Ko J.-C.; Lin C.-K.; Ho C.-C.; JIN-YUAN SHIH |
| 臺大學術典藏 |
2021-09-17T05:56:07Z |
Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma
|
Liang S.-K.; Hsieh M.-S.; Lee M.-R.; LI-TA KENG; Ko J.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2021-09-17T05:56:06Z |
Cementing an unwanted relationship
|
Chang C.-H.; LI-TA KENG; Ko J.-C. |
| 臺大學術典藏 |
2021-09-17T05:56:03Z |
Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort
|
Liang S.-K.; LI-TA KENG; Chang C.-H.; Wen Y.-F.; Lee M.-R.; Yang C.-Y.; Wang J.-Y.; Ko J.-C.; Shih J.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2021-09-17T05:56:03Z |
Exploring volatile organic compounds in breath for high-accuracy prediction of lung cancer
|
Tsou P.-H.; Lin Z.-L.; Pan Y.-C.; Yang H.-C.; Chang C.-J.; Liang S.-K.; Wen Y.-F.; Chang C.-H.; Chang L.-Y.; Yu K.-L.; Liu C.-J.; LI-TA KENG; Lee M.-R.; Ko J.-C.; Huang G.-H.; Li Y.-K. |
| 臺大學術典藏 |
2021-09-17T05:56:02Z |
Functional Status After Pulmonary Rehabilitation as a Predictor of Weaning Success and Survival in Patients Requiring Prolonged Mechanical Ventilation
|
LI-TA KENG; Liang S.-K.; Tseng C.-P.; Wen Y.-F.; Tsou P.-H.; Chang C.-H.; Chang L.-Y.; Yu K.-L.; Lee M.-R.; Ko J.-C. |
| 臺大學術典藏 |
2021-09-17T05:41:27Z |
Tuberculosis contact investigation in an intermediate burden setting: implications from a large tuberculosis contact cohort in Taiwan
|
Lee M.-R.; Ho C.-M.; Lee C.-H.; Lee M.-C.; Chang L.-Y.; KAI-LUN YU; Ko J.-C.; Wang J.-Y.; Wang J.-T.; Lee L.-N. |
| 臺大學術典藏 |
2021-09-17T05:41:25Z |
Outcome of stage IV cancer patients receiving in-hospital cardiopulmonary resuscitation: a population-based cohort study
|
Lee M.-R.; KAI-LUN YU; Kuo H.-Y.; Liu T.-H.; Ko J.-C.; Tsai J.-S.; Wang J.-Y. |
| 臺大學術典藏 |
2021-09-17T05:41:24Z |
Exploring volatile organic compounds in breath for high-accuracy prediction of lung cancer
|
Tsou P.-H.; Lin Z.-L.; Pan Y.-C.; Yang H.-C.; Chang C.-J.; Liang S.-K.; Wen Y.-F.; Chang C.-H.; Chang L.-Y.; KAI-LUN YU; Liu C.-J.; Keng L.-T.; Lee M.-R.; Ko J.-C.; Huang G.-H.; Li Y.-K. |
| 臺大學術典藏 |
2021-09-17T05:41:23Z |
Efficacy and safety of cone-beam computed tomography-derived augmented fluoroscopy combined with endobronchial ultrasound in peripheral pulmonary lesions
|
KAI-LUN YU; Yang S.-M.; Ko H.-J.; Tsai H.-Y.; Ko J.-C.; Lin C.-K.; Ho C.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2021-09-17T05:41:23Z |
Functional Status After Pulmonary Rehabilitation as a Predictor of Weaning Success and Survival in Patients Requiring Prolonged Mechanical Ventilation
|
Keng L.-T.; Liang S.-K.; Tseng C.-P.; Wen Y.-F.; Tsou P.-H.; Chang C.-H.; Chang L.-Y.; KAI-LUN YU; Lee M.-R.; Ko J.-C. |
| 臺大學術典藏 |
2021-09-17T03:21:20Z |
Bacteraemia caused by Mycobacterium abscessus subsp. abscessus and M. abscessus subsp. bolletii: Clinical features and susceptibilities of the isolates
|
Lee M.-R.; Ko J.-C.; SHENG-KAI LIANG; Lee S.-W.; Yen D.H.-T.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-09-17T03:21:19Z |
Vorinostat enhances the cisplatin-mediated anticancer effects in small cell lung cancer cells
|
Pan C.-H.; Chang Y.-F.; Lee M.-S.; Wen B.-C.; Ko J.-C.; SHENG-KAI LIANG; Liang M.-C. |
| 臺大學術典藏 |
2021-09-17T03:21:19Z |
Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma
|
SHENG-KAI LIANG; Hsieh M.-S.; Lee M.-R.; Keng L.-T.; Ko J.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2021-09-17T03:21:18Z |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study
|
SHENG-KAI LIANG; Lee M.-R.; Liao W.-Y.; Ho C.-C.; Ko J.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2021-09-17T03:21:17Z |
Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutations
|
SHENG-KAI LIANG; Ko J.-C.; Yang J.C.-H.; Shih J.-Y. |
